Nucaps Nanotechnology - About the company
Nucaps Nanotechnology is a seed company based in Noain (Spain), founded in 2016. It operates as a Provider of encapsulation technology for developing nanocapsules and biocapsules. Nucaps Nanotechnology has raised $440K in funding from UN I+D+i Tech Transfer. The company has 2649 active competitors, including 877 funded and 627 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.
Company Details
NUCAPS provides encapsulation technology for developing nanocapsules and biocapsules. Its product includes a protein-based dry powder that can be filled in a capsule/sachet/pill. It is claimed to increase the solubility of the active compound and form stable suspensions in liquids. Additionally, it provides encapsulation services for bioactive and probiotics capsules. Its offerings have applications in the nutrition, food, pharmaceutical, cosmetics, and healthcare industries. The company also provides IP licenses for applications of its technology in multiple markets and owns 4 international patents for its protein-based nano/biocapsules. The company was found by a collaboration between CNTA, IDIFARMA, and the University of Navarra.
- Email ID
- *****@nucapsnanotechnology.com
Key Metrics
Founded Year
2016
Location
Noain, Spain
Stage
Seed
Total Funding
$440K in 3 rounds
Latest Funding Round
Investors
Ranked
884th among 2649 active competitors
Employee Count
20 as on Sep 30, 2026
Similar Companies
Sign up to download Nucaps Nanotechnology's company profile
Nucaps Nanotechnology's funding and investors
Nucaps Nanotechnology has raised a total funding of $440K over 3 rounds. Its first funding round was on 2020. Its latest funding round was a Grant (prize money) round on Sep 11, 2024 for $*****. 1 investor participated in its latest round. Nucaps Nanotechnology has 6 institutional investors.
Here is the list of recent funding rounds of Nucaps Nanotechnology:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 11, 2024 | 3865934 | Grant (prize money) | 2604297 | 3709998 | 6142848 | 8369185 |
Nov 22, 2023 | 7763676 | Conventional Debt | 4108904 | 3913129 | 8409225 | |
2020 | 9512 | Seed | 3736 | 5677 | 3286 |
View details of Nucaps Nanotechnology's funding rounds and investors
Nucaps Nanotechnology's founders and board of directors
Founder? Claim ProfileNucaps Nanotechnology's employee count trend
Nucaps Nanotechnology has 20 employees as of Sep 26. Here is Nucaps Nanotechnology's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Nucaps Nanotechnology's Competitors and alternates
Top competitors of Nucaps Nanotechnology include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of Nucaps Nanotechnology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd | Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 72/100 | |
3rd | Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
4th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
5th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 71/100 | ||
6th | Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
7th | Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders | $69.7M | 70/100 | ||
8th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 70/100 | |
9th | Deciphera 2003, Waltham (United States), Acquired | Developer of type 2 kinase inhibitors for treating cancer | $173M | 70/100 | |
10th | Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 69/100 | |
884th | Nucaps Nanotechnology 2016, Noain (Spain), Seed | Provider of encapsulation technology for developing nanocapsules and biocapsules | $440K | 38/100 |
Looking for more details on Nucaps Nanotechnology's competitors? Click here to see the top ones
Nucaps Nanotechnology's Investments and acquisitions
Nucaps Nanotechnology has made no investments or acquisitions yet.
Reports related to Nucaps Nanotechnology
Here is the latest report on Nucaps Nanotechnology's sector:
News related to Nucaps Nanotechnology
•
Sodena facilitates the financing round of Nucaps with a loan of €150,000Webcapitalriesgo•Nov 22, 2023•Sodena, Nucaps Nanotechnology
•
Nucaps wins the first edition of Scale the Impact, the Danone and Social Nest Foundation acceleration programEl Referente•Jun 09, 2023•Nucaps Nanotechnology
Are you a Founder ?
FAQs about Nucaps Nanotechnology
Explore our recently published companies
- Homeschool Facts - Unfunded company
- Canbas Bio - Tangerang based, 2018 founded, Unfunded company
- BioNordika - Finland based, 1995 founded, Public company
- Shangkentech.com - 2018 founded, Unfunded company
- Innovsense.com - 2022 founded, Unfunded company
- Jupho - Mumbai based, Unfunded company
